Search

everythinglearnresearchcommunity

for

Search:↓

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Androgen levels do not determine the type of PCOS symptoms in young females.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Effective acne management in PCOS includes hormone therapy, metformin, isotretinoin, weight loss, diet, exercise, and personalized treatment plans.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.